Viewing Study NCT04504669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-01-03 @ 8:23 PM
Study NCT ID: NCT04504669
Status: COMPLETED
Last Update Posted: 2024-11-05
First Post: 2020-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clear Cell Renal Cell Cancer View
None Non-Small-Cell Lung Cancer View
None Triple Negative Breast Neoplasms View
None Squamous Cell Cancer of Head and Neck View
None Small Cell Lung Cancer View
None Gastroesophageal Cancer View
None Melanoma View
None Cervical Cancer View
None Advanced Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumours View
None Durvalumab View
None MEDI4736 View
None AZD8701 View
None Non Small cell Lung cancer View
None ccRenal Cancer View
None TNBC View
None first time in human View
None PD-L1 View
None T regulatory cells View
None FOXP3 View